CD22 Human Monoclonal Antibody
Anti-Human CD22 (BO193) is a research-grade recombinant antibody targeting CD22. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Sialic acid-binding Ig-like lectin 2, Siglec-2, CD22, T-cell surface antigen Leu-14, BL-CAM, SIGLEC2, B-lymphocyte cell adhesion molecule, B-cell receptor CD22
UniProt
P20273
Reactivity
Human
Clonality
Monoclonal
Clone
BO193
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
IgG1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNCB2876-100 1x 100 µL
CD31 / PECAM-1 (Endothelial Cell Marker) (C31/2876R), Biotin conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
